BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37897875)

  • 1. Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals.
    Olecki EJ; Perez Holguin RA; Mayhew MM; Wong WG; Vining CC; Peng JS; Shen C; Dixon MEB
    J Surg Res; 2024 Feb; 294():160-168. PubMed ID: 37897875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals.
    Lima HA; Alaimo L; Moazzam Z; Endo Y; Woldesenbet S; Katayama E; Munir MM; Shaikh C; Ruff SM; Dillhoff M; Beane J; Cloyd J; Ejaz A; Resende V; Pawlik TM
    Ann Surg Oncol; 2023 Jul; 30(7):4363-4372. PubMed ID: 36800128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in NCCN Guideline Compliant Care for Resectable Cholangiocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.
    Tsilimigras DI; Dalmacy D; Hyer JM; Diaz A; Abbas A; Pawlik TM
    Ann Surg Oncol; 2021 Dec; 28(13):8162-8171. PubMed ID: 34036428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
    Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
    JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in guideline-compliant care for patients with pancreatic ductal adenocarcinoma at minority-versus non-minority-serving hospitals.
    Elshami M; Hoehn RS; Ammori JB; Hardacre JM; Selfridge JE; Bajor D; Mohamed A; Chakrabarti S; Mahipal A; Winter JM; Ocuin LM
    HPB (Oxford); 2023 Dec; 25(12):1502-1512. PubMed ID: 37558565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
    Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare disparities in outcomes of patients with resectable pancreatic cancer.
    Moaven O; Richman JS; Reddy S; Wang T; Heslin MJ; Contreras CM
    Am J Surg; 2019 Apr; 217(4):725-731. PubMed ID: 30583797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.
    Deboever N; Correa AM; Feldman H; Mathur U; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Walsh GL; Vaporciyan AA; Antonoff MB; Rajaram R
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):329-337.e4. PubMed ID: 37116780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Minority-Serving Hospital Status with Post-Discharge Care Utilization and Expenditures in Gastrointestinal Cancer.
    Lima HA; Woldesenbet S; Moazzam Z; Endo Y; Munir MM; Shaikh C; Rueda BO; Alaimo L; Resende V; Pawlik TM
    Ann Surg Oncol; 2023 Nov; 30(12):7217-7225. PubMed ID: 37605082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Disparities in Treatment for Rectal Cancer at Minority-Serving Hospitals.
    Lu PW; Scully RE; Fields AC; Welten VM; Lipsitz SR; Trinh QD; Haider A; Weissman JS; Freund KM; Melnitchouk N
    J Gastrointest Surg; 2021 Jul; 25(7):1847-1856. PubMed ID: 32725520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
    Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
    Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Adenocarcinoma in New Mexico Native Americans: Disparities in Treatment and Survival.
    Greenbaum A; Alkhalili E; Rodriguez R; Caldwell K; O'Neill J; Munoz OE; Qeadan F; Myers O; Nir I; Morris KT
    J Health Care Poor Underserved; 2019; 30(2):609-617. PubMed ID: 31130540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma.
    Molina G; Clancy TE; Tsai TC; Lam M; Wang J
    Ann Surg Oncol; 2021 Feb; 28(2):1088-1096. PubMed ID: 32651695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in Care: Impact of Socioeconomic Factors on Pancreatic Surgery: Exploring the National Cancer Database.
    Makar M; Worple E; Dove J; Hunsinger M; Arora T; Oxenberg J; Blansfield JA
    Am Surg; 2019 Apr; 85(4):327-334. PubMed ID: 31043190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes.
    Riner AN; Underwood PW; Yang K; Herremans KM; Cameron ME; Chamala S; Qiu P; George TJ; Permuth JB; Merchant NB; Trevino JG
    Cancer Med; 2020 Jun; 9(12):4069-4082. PubMed ID: 32285629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.
    Riall TS; Townsend CM; Kuo YF; Freeman JL; Goodwin JS
    Cancer; 2010 Feb; 116(4):930-9. PubMed ID: 20052726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study.
    Tohme S; Kaltenmeier C; Bou-Samra P; Varley PR; Tsung A
    Ann Surg Oncol; 2018 Nov; 25(12):3427-3435. PubMed ID: 30043318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
    Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
    Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.